As of 2025-07-05, the EV/EBITDA ratio of Xtant Medical Holdings Inc (XTNT) is -37.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XTNT's latest enterprise value is 124.88 mil USD. XTNT's TTM EBITDA according to its financial statements is -3.30 mil USD. Dividing these 2 quantities gives us the above XTNT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 7.4x | 5.8x |
| Forward P/E multiples | 5.8x - 7.9x | 7.3x |
| Fair Price | (0.34) - (0.38) | (0.36) |
| Upside | -149.6% - -154.9% | -152.0% |
| Date | EV/EBITDA |
| 2025-06-26 | -34.60 |
| 2025-06-25 | -35.37 |
| 2025-06-24 | -35.45 |
| 2025-06-23 | -33.51 |
| 2025-06-20 | -33.89 |
| 2025-06-18 | -33.46 |
| 2025-06-17 | -33.94 |
| 2025-06-16 | -34.88 |
| 2025-06-13 | -34.88 |
| 2025-06-12 | -36.04 |
| 2025-06-11 | -37.00 |
| 2025-06-10 | -36.89 |
| 2025-06-09 | -36.89 |
| 2025-06-06 | -37.94 |
| 2025-06-05 | -38.46 |
| 2025-06-04 | -37.39 |
| 2025-06-03 | -37.12 |
| 2025-06-02 | -36.50 |
| 2025-05-30 | -36.48 |
| 2025-05-29 | -38.11 |
| 2025-05-28 | -38.49 |
| 2025-05-27 | -37.39 |
| 2025-05-23 | -39.71 |
| 2025-05-22 | -39.27 |
| 2025-05-21 | -37.74 |
| 2025-05-20 | -38.24 |
| 2025-05-19 | -38.79 |
| 2025-05-16 | -36.57 |
| 2025-05-15 | -35.69 |
| 2025-05-14 | -34.76 |
| 2025-05-13 | -33.79 |
| 2025-05-12 | -30.56 |
| 2025-05-09 | -29.92 |
| 2025-05-08 | -31.28 |
| 2025-05-07 | -30.49 |
| 2025-05-06 | -30.08 |
| 2025-05-05 | -29.82 |
| 2025-05-02 | -28.54 |
| 2025-05-01 | -28.41 |
| 2025-04-30 | -30.06 |
| 2025-04-29 | -29.28 |
| 2025-04-28 | -28.87 |
| 2025-04-25 | -30.14 |
| 2025-04-24 | -28.87 |
| 2025-04-23 | -27.44 |
| 2025-04-22 | -28.80 |
| 2025-04-21 | -29.37 |
| 2025-04-17 | -27.57 |
| 2025-04-16 | -25.29 |
| 2025-04-15 | -25.08 |